首页> 外国专利> Rationally designed meganucleases with sequence specificity and altered DNA binding affinity

Rationally designed meganucleases with sequence specificity and altered DNA binding affinity

机译:合理设计的大范围核酸酶具有序列特异性和改变的DNA结合亲和力

摘要

A method for producing a recombinant meganuclease that has specificity for a semisite of altered recognition sequence that differs by at least one base pair from a semisite within a recognition sequence of the I-Crel meganuclease selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, said method comprising: A. designing a polypeptide sequence having a similarity of at least 85% with residues 2-153 of the I-Crel meganuclease of SEQ ID NO: 1, said design comprising modifying the sequence of residues 2-153 of the I-Crel meganuclease of SEQ ID NO: 1, where (1) the specificity in the position -1: (a) to a T in a coding strand by a modification selected from the group consisting of C70, L70, Y75, Q75, H75, H139, Q46 and H46; (b) to an A in a coding strand by a modification selected from the group consisting of Y75, L75, C75, Y139, C46 and A46; (c) to a G in a coding strand by a modification selected from the group consisting of E70, E75, E46 and D46; (d) to a C in a coding strand by a modification selected from the group consisting of H75, R75, H46, K46 and R46; or (e) to any base in a coding strand by a modification of G46; and / or (2) the specificity in a position -2 has been altered: (a) to an A in a coding strand 81 by a modification selected from the group consisting of V44, I44, L44 and N44; (b) to a C in a coding strand by a modification of E70; (c) to an A or a T in a coding strand by a modification comprising C44; and / or (3) the specificity in a position -3 has been altered: (a) to an A in a coding strand by a modification of C24; (b) to a C in a coding strand by a modification selected from the group consisting of F68, K24 and R24; (c) to a T in a coding strand by a modification selected from the group consisting of M68, C68, L68 and F68; (d) to a C or a T in a coding strand by a modification comprising Y68; and / or (4) the specificity in a position -4 has been altered: (a) to a C in a coding strand by a modification selected from the group consisting of E77 and K26; (b) to a G in a coding strand by a modification selected from the group consisting of E26 and R77; (c) to a C or a T in a coding strand by a modification comprising S77; or (d) to any base in a coding strand by means of a modification comprising S26, and / or (5) the specificity in a position -5 has been altered: (a) to a C in a coding strand by a modification comprising E42; (b) to a G in a coding strand by a modification comprising R42; (c) to an A or a G in a coding strand by a modification selected from the group consisting of C28 and Q42; or (d) to any base in a coding strand by a modification selected from the group consisting of M66 and K66; and / or (6) the specificity in a -6 position has been altered: (a) to a T in a coding strand by a modification selected from the group consisting of 60 C40, I40, V40, C79, I79, V79 and Q28; (b) to a C in a coding strand by a modification selected from the group consisting of E40 and R28; or (c) to a G in a coding strand by a modification comprising R40; and / or (7) the specificity in a position -7 has been altered: (a) to a C in a coding strand by a modification selected from the group consisting of E38, K30 and R30; (b) to a G in a coding strand by a modification selected from the group consisting of K38, R38 and E30; (c) to a T in a coding strand by a modification selected from the group consisting of I38 and L38; or (d) to an A or a G in a coding strand by a modification comprising C38; or (e) to any base in a coding strand by a modification selected from the group consisting of H38, N38 and Q30; and / or (8) the specificity in a position -8 has been altered: (a) to a T in a coding strand by a modification selected from the group consisting of L33, V33, I33, F33 and C33; (b) to a C in a coding strand by a modification selected from the group consisting of E33 and D33; (c) to a G in a coding strand by a modification consisting of K33; or (d) to an A or a C in a coding strand by a modification comprising R32; or (e) to an A or a G in a coding strand by a modification comprising R33; and / or (9) the specificity in a position -9 has been altered: (a) to a C in a coding strand by a modification comprising E32; (b) to a G in a coding strand by a modification selected from the group consisting of R32 and K32; (c) to a T in a coding strand by a modification selected from the group consisting of L32, V32, A32 and C32; (d) to a C or a T in a coding strand by a modification selected from the group consisting of D32 and I32; or (e) to any base in a coding strand by a modification selected from the group consisting of S32, N32, H32, Q32 and T32, wherein said polypeptide sequence does not comprise residues 2-153 of the I-Crel meganuclease SEQ ID NO: 1 only with the following modifications that alter the specificity: N75, A68 / N70 / N75, D44 / K70 / N75, R44 / AG8 / T70 / N75, A44 / L70 / N75, A44 / D68 / K70 / N75, A44 / G68 / N75, K44 / T68 / G70 / N75, D44 / N70 / N75, A44 / T68 / S70 / N75, R44 / N70 / N75, A44 / S68 / N75, A26, C26, C26 / R66, R66, C33, H33, T68 / K70 / N75, K70 / N75, N70 / N75, T70 / N75, A70 / N75, T44 / N75, A68 / K70 / N75, N68 / K70 / N75, G70 / N75, SG8 / K70 / N75, N68 / N75, H70 / N75, S70 / N75, G68 / K70 / N75, Q70 / N75, Q68 / K70 / N75, H68 / K70 / N75, A32, A140, F33, A30, A44, A38, A44 / A140, K32, R32, N33, R33, A68, A33, G33, I33, K33, L33, P33, Q33, S33, T33, A28, A70, D33, E33, M33, V33 and W33; and B. producing a recombinant meganuclease comprising said polypeptide sequence.
机译:一种产生重组大范围核酸酶的方法,其对改变的识别序列的半位点具有特异性,该半序列与选自SEQ ID NO:2的I-Crel大范围核酸酶的识别序列内的半位点相差至少一个碱基对。 SEQ ID NO:3,SEQ ID NO:4和SEQ ID NO:5,所述方法包括:A.设计与SEQ ID NO:1的C-Crel大范围核酸酶的残基2-153具有至少85%相似性的多肽序列。 NO:1,所述设计包括修饰SEQ ID NO:1的I-Crel大范围核酸酶的残基2-153的序列,其中(1)在位置-1的特异性:(a)对编码链中的T的特异性通过选自C70,L70,Y75,Q75,H75,H139,Q46和H46的修饰; (b)通过选自Y75,L75,C75,Y139,C46和A46的修饰为编码链中的A; (c)通过选自E70,E75,E46和D46的修饰在编码链中形成G; (d)通过选自H75,R75,H46,K46和R46的修饰在编码链中形成C; (e)通过修饰G46形成编码链中的任何碱基;或和/或(2)位置-2的特异性已被改变:(a)通过选自V44,I44,L44和N44的修饰为编码链81中的A; (b)通过修饰E70形成编码链中的C; (c)通过包含C44的修饰形成编码链中的A或T;和/或(3)-3位的特异性已经改变:(a)通过修饰C24变为编码链中的A; (b)通过选自F68,K24和R24的修饰而形成编码链中的C; (c)通过选自M68,C68,L68和F68的修饰为编码链中的T; (d)通过包含Y68的修饰形成编码链中的C或T;和/或(4)在-4位的特异性已经改变:(a)通过选自E77和K26的修饰在编码链中的C; (b)通过选自由E26和R77组成的组的修饰在编码链中形成G; (c)通过包含S77的修饰为编码链中的C或T; (d)通过包含S26的修饰而改变为编码链中的任何碱基,和/或(5)已改变-5位的特异性:(a)通过包含E42; (b)通过包含R42的修饰形成编码链中的G; (c)通过选自C28和Q42的修饰而形成编码链中的A或G; (d)通过选自M66和K66的修饰对编码链中的任何碱基进行修饰;或和/或(6)在-6位上的特异性已改变:(a)通过选自60 C40,I40,V40,C79,I79,V79和Q28的修饰为编码链中的T ; (b)通过选自由E40和R28组成的组的修饰在编码链中形成C; (c)通过包含R40的修饰形成编码链中的G;和/或(7)-7位的特异性已经改变:(a)通过选自E38,K30和R30的修饰在编码链中的C; (b)通过选自由K38,R38和E30组成的组中的修饰而形成编码链中的G; (c)通过选自I38和L38的修饰而形成编码链中的T; (d)通过包含C38的修饰形成编码链中的A或G; (e)通过选自H38,N38和Q30的修饰对编码链中的任何碱基进行修饰;或和/或(8)已经改变了-8位的特异性:(a)通过选自L33,V33,I33,F33和C33的修饰为编码链中的T; (b)通过选自E33和D33的修饰而形成编码链中的C; (c)通过由K33组成的修饰而形成编码链中的G; (d)通过包含R32的修饰形成编码链中的A或C;或(e)通过包含R33的修饰形成编码链中的A或G;和/或(9)-9位的特异性已经改变:(a)通过包含E32的修饰在编码链中的C; (b)通过选自R32和K32的修饰而形成编码链中的G; (c)通过选自L32,V32,A32和C32的修饰在编码链中的T; (d)通过选自D32和I32的修饰而形成编码链中的C或T; (e)通过选自由S32,N32,H32,Q32和T32组成的组的修饰对编码链中的任何碱基进行修饰,其中所述多肽序列不包含I-Crel大范围核酸酶SEQ ID NO的残基2-153 :1仅具有以下改变特异性的修饰:N75,A68 / N70 / N75,D44 / K70 / N75,R44 / AG8 / T70 / N75,A44 / L70 / N75,A44 / D68 / K70 / N75,A44 / G68 / N75,K44 / T68 / G70 / N75,D44 / N70 / N75,A44 / T68 / S70 / N75,R44 / N70 / N75,A44 / S68 / N75,A26,C26,C26 / R66,R66,C33,H33,T68 / K70 / N75,K70 / N75 ,N70 / N75,T70 / N75,A70 / N75,T44 / N75,A68 / K70 / N75,N68 / K70 / N75,G70 / N75,SG8 / K70 / N75,N68 / N75,H70 / N75,S70 / N75 ,G68 / K70 / N75,Q70 / N75,Q68 / K70 / N75,H68 / K70 / N75,A32,A140,F33,A30,A44,A38,A44 / A140,K32,R32,N33,R33,A68,A33 ,G33,I33,K33,L33,P33,Q33,S33,T33,A28,A70,D33,E33,M33,V33和W33; B.产生包含所述多肽序列的重组大范围核酸酶。

著录项

  • 公开/公告号ES2602184T3

    专利类型

  • 公开/公告日2017-02-20

    原文格式PDF

  • 申请/专利权人 PRECISION BIOSCIENCES;

    申请/专利号ES20130164564T

  • 发明设计人 HELLINGA HOMME;SMITH JAMES;JANTZ DEREK;

    申请日2006-10-18

  • 分类号C12N9/22;C12N15/90;

  • 国家 ES

  • 入库时间 2022-08-21 13:35:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号